Predictive risk factors of steroid dependent nephrotic syndrome in children

Maher Ahmed Abdel-Hafez1, Nagy Mohamed Abou-El-Hana1, Adel Ali Erfan1

  • 1Pediatric Department, Faculty of Medicine, Tanta University, Egypt.

Insights

Predicting steroid dependency in children with nephrotic syndrome is crucial. Early indicators include cumulative steroid dose within six months and time to initial remission, aiding treatment strategies.

Area of Science:

  • Pediatric Nephrology
  • Clinical Pediatrics

Background:

  • Steroid dependency poses challenges in managing childhood idiopathic nephrotic syndrome, increasing morbidity and treatment costs.
  • Early prediction of steroid dependency can guide parental counseling and refine treatment strategies for pediatric nephrotic syndrome.

Purpose of the Study:

  • To identify early clinical predictors of steroid dependency in children with steroid-sensitive nephrotic syndrome (SSNS).
  • To aid in the early management of SSNS by identifying risk factors for steroid dependency.

Main Methods:

  • Retrospective analysis of 52 children (ages 3-16) diagnosed with SSNS.
  • Patients were categorized into two groups: steroid-dependent/frequent relapsers (n=24) and complete remission/recurrent (n=28).

Main Results:

  • Children needing >140 mg/kg cumulative steroid dose in the first 6 months are at high risk for requiring steroid-sparing agents.
  • Failure to achieve remission by day 20 of initial prednisone treatment predicted steroid dependency with 96% specificity.
  • Relapses in steroid-dependent children were significantly associated with upper respiratory tract infections.

Conclusions:

  • Cumulative steroid dose within the initial six months is a key predictor of steroid dependency in pediatric nephrotic syndrome.
  • The duration to achieve initial remission (over 20 days) is another significant factor in predicting steroid dependency.
Abstract

Related Concept Videos

Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
721
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
265
Nephrotic Syndrome III : Nursing Management01:24

Nephrotic Syndrome III : Nursing Management

Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...
367
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
302
Drug Toxicity: Risk factors01:24

Drug Toxicity: Risk factors

Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
38
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
354